Earlier this year, Celgene passed on an exclusive option to buy Acetylon Pharmaceuticals. But surprisingly, the two companies have come up with a new deal instead. Celgene agreed Friday to acquire just a portion of the assets of the Boston... Read more »
Xconomy is sad to report that Katie Vale, a mainstay of the New England education and technology community, passed away unexpectedly on Sunday, Nov. 27. She was 51.
Vale was a close friend of the Xconomy family and participated in many... Read more »
With sales of its minimally invasive heart valve growing in Europe and an expected launch of the product coming in the United States, Boston Scientific is now shoring up the resources behind its Lotus Valve System with a deal to acquire... Read more »
Healthcare news has been coming fast and furious in the fallout of the election, particularly this week. Read on below for the latest on the 21st Century Cures Act, the Trump Administration’s latest nominees, and a biopharma CEO’s warning to his... Read more »
We’ve packed some extra stuffing into the roundup this week to account for some burnt turkey delivered by biopharma in the few days before Thanksgiving—starting with Eli Lilly’s failed gamble in Alzheimer’s disease.
Lilly wasn’t alone, however. Several companies, among them... Read more »
‘Tis the holiday season, and in this week’s roundup of Boston-area tech news, we’re covering funding for a pop-up greeting card startup and an initiative that encourages people to, instead of giving gifts, donate to nonprofits that support causes considered at... Read more »
The State of Cybersecurity, Xconomy’s first-ever dedicated conference on cybersecurity, is just one week away! It all takes place in WGBH’s auditorium in Boston at 1:30pm on Thursday, Dec. 8. Now’s your chance to save a little extra cash during... Read more »
The methods of honing the skills of sales people are getting more sophisticated, as companies turn to mobile technologies, data analytics, and even neuroscience to coax the best performance possible from their sales teams.
Investors see promise here: Qstream announced today... Read more »
By a 392 to 26 vote, the U.S. House of Representatives has passed the omnibus healthcare legislation called the 21st Century Cures Act, bringing new funding for top Obama administration health priorities a big step closer to the outgoing president’s signature.... Read more »
Several drugs have been approved to treat multiple myeloma, a cancer of the bone marrow, in recent years. But it remains a nasty, persistent disease. Most everyone relapses.
Two rival groups, Bluebird Bio and researchers at the University of Pennsylvania, are... Read more »
Founder Collective has reloaded its stock of dry powder to fuel young startups. The venture firm today announced it has raised $75 million for its third fund, roughly the same aggregate size as its second.
The firm was founded by a... Read more »
An increased incidence of counterfeit drugs around the world has people worried about the health problems they can cause, among other issues.
That’s sparked a wave of interest in companies that are creating technologies to potentially sniff out counterfeit drugs. Now,... Read more »
We’re still a long way from understanding how the trillions of bacteria that live in and on our bodies, known collectively as the human microbiome, affect our health and well-being. Despite those unknowns, a steady drip of companies have launched in... Read more »